U.S. drug prices to rise in 2020 as companies prepare to charge more for Ibrance, Xeljanz, 200 others

📆 03-01-20 22:03:00
📰 HealthyWomen

⏱ Reading Time:
21 sec. here
2 min. at publisher
📊 Quality Score:
News: 12%
Publisher: 68%

Belgique Nouvelles Nouvelles

Belgique Dernières Nouvelles,Belgique Actualités

Drugmakers on Wednesday hiked US list prices on more than 50 drugs. prescriptions

Expect to pay more for some prescription drugs in 2020 as pharmaceutical companies such as Pfizer, GlaxoSmithKline PLC and Sanofi SA will institute a price hike on over 200 drugs beginning Wednesday, according to 3 Axis Advisors, a healthcare data analysis firm.

The breast cancer medication Ibrance and arthritis medication Xeljanz, both manufactured by Pfizer, are expected to be around five percent more expensive. GlaxoSmithKline is expected to raise prices on approximately 30 of its products, including the COPD and asthma medication, Ellipta, and the cancer drug, Zejula. Pharmaceutical manufacturer Sanofi is expected to increase the price of 10 of its drugs.

Écrire un Commentaire

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

Belgique Dernières Nouvelles, Belgique Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Tesla stock price could surge 23% in 2020 according to one analyst - Business InsiderJed Dorsheimer of Canaccord Genuity, raised his price target to $515 from $375 Thursday, saying electric vehicles will 'only accelerate in 2020.'
La source: BusinessInsider - 🏆 729. / 51 Lire la suite »